Albest Tablets
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Highple Life Science Co., Ltd.
MFDS item code 201904789 · Approved 2019.07.17
This product's status changed to Approval withdrawn on 2024.03.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (ulcers, gastritis, etc.) and prevention of Mendelson syndrome before anesthesia
This medication is used in the treatment of ulcers of the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome prior to anesthesia and is effective in preventing ulcers after surgery. It is used to treat gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This drug helps improve symptoms by protecting the gastric mucosa and regulating acid secretion. It is widely used to effectively manage the gastric health of patients.
○ Adults Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to the treatment of ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to concomitant treatment to prevent gastric or duodenal ulcers during long-term NSAID use. Conditions caused by NSAID use usually heal within 4 weeks, while ulcers generally heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets four times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets three times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Pre-anesthetic medication (prevention of Mendelson syndrome) Take 2 tablets 2 hours before induction of anesthesia. It is also preferable to take 2 tablets on the night before surgery.
This drug should not be used in patients undergoing dialysis or those with impaired kidney function. Moreover, it should not be administered to patients with a history of allergy to this drug or its components, patients with acute porphyria, those who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants, newborns, and patients who need to restrict potassium intake. Patients with liver dysfunction or a history of drug allergies, the elderly, and those who take non-steroidal anti-inflammatory drugs concurrently should use this drug cautiously, especially because it may mask symptoms of gastric cancer. Patients with gastric ulcers or newly manifested indigestion symptoms over middle age should ensure malignancy is ruled out before use. For patients with gastric or duodenal ulcers infected with Helicobacter pylori, efforts to eliminate bacteria are necessary. Caution is also required for severely ill patients hospitalized in the intensive care unit, patients with hypophosphatemia, and patients who have difficulty swallowing. Rarely, serious allergic reactions like anaphylactic shock can occur while using this drug; if unusual symptoms manifest, administration should be stopped immediately, and appropriate treatment should be sought. Various side effects such as skin rash, urticaria, respiratory issues, blood abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, neurological symptoms, muscle pain, and hair loss may occur, so consultation with medical personnel is advised if such symptoms appear. Long-term use of this drug is not recommended, and symptoms, blood, liver, and kidney function should be monitored periodically during treatment. It is safe to avoid driving or operating hazardous machinery if dizziness or drowsiness occurs. Additionally, this drug may interact with other medications; therefore, if other drugs are being taken, patients must inform medical personnel, particularly regarding anticoagulants, some antibiotics, and anticonvulsants. Pregnant or breastfeeding women should avoid using this drug, and its safety and efficacy in children have not been established, thus it is not recommended. In cases of overdose, measures such as vomiting or gastric lavage may be necessary, and in severe situations, removal via hemodialysis may also be required. Finally, as this drug reduces gastric acid secretion and may promote bacterial growth in the gastrointestinal tract, caution, including ophthalmological examinations, is necessary for long-term use.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent air exposure, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Storing in this manner helps maintain the drug's effectiveness for a longer period.
Green round film-coated tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Highple Life Science Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.